News

Our Latest News

ITL: Gene Testing:
Time Is Ripe in Work Comp

Gene testing is showing promise as a tool to get the right medication at the right dose to each workers' compensation patient.

Pharmacogenetic testing (PGT) has the potential to help clinicians improve outcomes for injured workers and reduce costs for payers. While research showing the clinical value of PGT continues to grow rapidly, evidence of the return on investment in the workers’ comp space is just beginning to emerge. Practitioners can benefit from the technology without falling victim to the hype of some proponents by becoming better educated about PGT and those providing it.Read More

Clinical Study Shows Lab-based Urine Drug Monitoring, Interventions Improve Outcomes for Injured Workers on Chronic Opioid Therapy

High-risk Medication Utilization, Abuse Reduced

Memphis, Tenn. and San Diego, Calif. (April 24, 2014) — Clinical interventions performed in conjunction with laboratory quantitative drug testing and monitoring were shown to reduce utilization of high risk medications in injured workers on chronic opioid therapy, according to a clinical study released by the merged entity of Progressive Medical and PMSI, in partnership with Millennium Health. Read More